ESS vs LIMNW
Essex Property Trust Inc (ESS) versus Liminatus Pharma, Inc. Warrants (LIMNW) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on US.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
LIMNW does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. LIMNW currently screens at market cap $0.
Not investment advice. Open the ESS and LIMNW stock pages for the full models.
Not investment advice.